The US Oncology Network Helps Practices Thrive Through Technology Implementation

July 27, 2020

Oncology practices are constantly evolving and navigating changes in the healthcare landscape. While the increasing complexity of administrative and operational responsibilities can bring about unforeseen burdens, The US Oncology Network’s technology implementation services and support help ease those challenges. Our team leads the implementation of processes and tools that enable our physicians to focus on delivering leading edge care to patients.

Building a technology roadmap and supporting implementation

The right technology is critical to operating a successful practice. Our deep understanding of oncology practices drives the development of an individualized technology roadmap that serves as a plan for practices to navigate the implementation of our industry-leading technologies to support core clinical, operational and financial aspects of the practice.

Read More

Practicing resiliency and self-care during challenging times

June 30, 2020

As the COVID-19 pandemic continues to make an impact across the country, The US Oncology Network is committed to ensuring that community oncology practices have the resources and tools necessary to navigate these stressful times. Even those who are typically strong and resilient in crisis situations can experience intense fear and anxiety about the unknown.

To support physicians and practice staff holistically during these unprecedented times, The Network offers helpful tools and information on Self-Care and Resiliency to assist with easing day-to-day stress and maintaining the well-being of physicians, practice staff and their families. Resources include podcasts, apps, websites and videos with topics ranging from practical ways to incorporate self-care to adapting to situations to balancing new routines are available.

Tips for self-care

To stay mentally strong during stressful times and times of uncertainty, consider incorporating the following tactics into your daily life:

Read More

Celebrating Oncology Nursing Month in 2020: The Year of the Nurse and Midwife

May 5, 2020

Celebrating Oncology Nursing Month in 2020: The Year of the Nurse and Midwife

Every May, we celebrate Oncology Nursing Month and recognize the critical role oncology nurses play in patient care. This year’s Oncology Nurses Month is of additional importance because 2020 is designated The Year of the Nurse and Midwife by the World Health Organization (WHO) in commemoration of Florence Nightingale’s 200th birthday. Further, it is the culmination of their three-year Nursing Now! campaign to elevate the status and recognition of nurses worldwide. 

Read More

The US Oncology Network’s Commitment to Helping Practices Navigate Difficult Times

April 15, 2020

As the COVID-19 pandemic continues to make an impact across the country, The US Oncology Network is committed to ensuring that community oncology practices have the resources and tools necessary to navigate this crisis. Through telemedicine support, IT, human resources, best practice sharing and communications we are committed to supporting practices to ensure they can continue to care for their patients during these unprecedented times.

We are diligently working on innovative strategies to support practices and their teams. Our COVID-19 task force continually monitors and evaluates to situation. Our decisions are based on recommendations from the Centers for Disease Control and Prevention (CDC), the American Society of Clinical Oncology (ASCO) and other federal, state and local agencies.

Communication with practices and patients

Read More

Proton Therapy Provides Real Value through Improved Outcomes and Quality of Life

May 30, 2019

Proton therapy is an advanced radiation therapy that uses protons to treat cancer rather than x-rays. Protons deliver the majority of their energy directly into the tumor and stop, minimizing exposure to adjacent healthy tissue. X-rays used in standard radiotherapy continue through the tumor, exposing patients to unnecessary radiation that can result in both short-and long-term side effects and secondary tumors. 

Read More

In-house Clinical Laboratory Services Benefit Practices and Patients Alike

September 26, 2018

Approximately 90% of oncology patients require a complete blood count (CBC) when they visit their oncologist for the first time. The CBC is used to evaluate a patient’s overall health and detect a wide range of disorders, including anemia, infection and leukemia.1 The test is especially critical in oncology, where cell counts can help guide important and time-sensitive treatment decisions, including whether to start or stop chemotherapy, identify if a patient needs a blood transfusion, or to make sure a patient’s bone marrow is functioning properly. In fact, nearly 70% of clinical decisions, including diagnosis and treatment, are based on CBC results.2

On-site lab allows for convenience and speed

Read More

Succeeding with the Oncology Care Model Requires Close Attention to Important Activities

July 17, 2018

By Marcus Neubauer, MD   |   July 2018

Since July of 2016, roughly 187 oncology practices across the country have been participating in the Oncology Care Model (OCM), the Center for Medicare & Medicaid Innovation’s (CMMI) new program designed to reduce the cost of care while improving quality and patient outcomes. Sixteen practices in The US Oncology Network (The Network) are participating in this care delivery/payment model, providing enhanced care to thousands of Medicare patients.

The Oncology Care Model is a very complex program, and there is a definite learning curve for practices trying to implement it. From input gathered so far across The Network, as well as from my own experience with the OCM, there are some critical activities that must be performed well to ensure success with the program.

Key Activities when Participating in the OCM

Read More

The US Oncology Network Advances Value-Based Care with Alternative Payment Models for Radiation Services

June 11, 2018

By David C. Fryefield, MD   |   June 2018

Radiation oncologists have been operating in a very challenging landscape for quite some time―one that has created unpredictable revenue streams for providers and made the delivery of quality care more difficult. Providers are under pressure from payers to reduce the number of treatments based on clinical trials demonstrating fewer treatments are as effective as a larger number in certain cancers. Innovative technologies are now part of the radiation oncologist’s toolkit, but these advances are driving up costs. As a result, prior authorization requirements and denials have greatly increased, dramatically impacting revenue and hindering the timely delivery of quality care.

New Payment Models Reduce Uncertainties

Read More

The US Oncology Network is Bringing Promising New CAR T-Cell Therapy Closer to Home

May 15, 2018

Those of us in the cancer community know that progress in the fight against cancer is often measured in very small steps. Certainly since I finished my fellowship, that has been the case. Over the last 30 years, treatment for many deadly cancers has usually involved substituting one chemotherapy drug for another, buying a patient time while increasing the cure rate by a mere percentage point or two.

Read More

The US Oncology Network Government Relations Team: Providing Policy Analysis & Strategic Advocacy for Community Cancer Care

April 27, 2018

Community oncology practices today face an increasingly complex web of government rules and regulations that can often inhibit practice success or viability. This complexity is having a direct impact on access to quality cancer care.  Eleven years ago, when I began my journey with The US Oncology Network (The Network), nearly 88% of all cancer care was delivered in the outpatient community setting. Today that figure is closer to 50%. This migration away from the community setting has a measurable impact on the healthcare ecosystem as hospital care is much more expensive for patients and payers. Conversely, helping community practices flourish is beneficial not only to patients and independent providers, but also to other key stakeholders in the cancer community. In today’s “value-driven” environment, it doesn’t make sense to continue enacting rules and regulations that accelerate this shift to the more expensive, less coordinated setting.

The Network Government Relations Team Is Hard at Work Protecting Community Cancer Care

Read More

The US Oncology Network Helps Practices Thrive Through Strategic Planning

March 26, 2018

Oncology is dramatically different today than when I entered the field 12 years ago. Practices are experiencing seismic changes in their environment and facing complex issues not previously encountered. While we cannot control the volatile landscape, strategic planning enables practices to prepare for what is coming, to take advantage of opportunities, and to set a direction for the practice that will position them for success.  

Building a roadmap to the future

Read More

The US Oncology Network: The Premier Employer for Advanced Practice Providers

February 2, 2018

Advanced Practice Providers (APPs) play a vital role in supporting practices across The US Oncology Network (The Network) delivering high quality care to patients. APPs are healthcare providers, including Nurse Practitioners and Physician Assistants, who have advanced education and are licensed in the state where they practice, and certified nationally. In oncology, these highly trained professionals work collaboratively with physicians, expanding and enhancing the care physicians provide patients.

The Network APP Program

Since joining The Network in 2015, I have seen substantial growth in our APP program. We now have nearly 400 of these highly skilled professionals working in a variety of specialties in nearly every practice across The Network. Most work in medical oncology, but we have growing numbers in surgical subspecialties and radiation oncology.

The overarching mission of APPs in The Network is to allow practices to see a high volume of patients while continuing to deliver quality care to everyone.

Read More

Unity Group Purchasing Organization Plays a Critical Role in Providing High Quality Affordable Cancer Care

January 11, 2018

By Barry Brooks, MD   |   January 2018

To remain strong and viable in today’s evolving healthcare landscape, practices must continually forge new relationships, embrace innovative tools and technologies, and seek more efficient ways of doing business and delivering care.

One of the most important developments I have seen over my career is the growing importance of group purchasing organizations (GPOs) and the increasing value they provide to community oncology. A GPO is an independent organization that contracts with pharmaceutical and biotechnology manufacturers to obtain discounted pricing on drugs and services on behalf of its membership.

Unity GPO: The leader in community oncology

Read More

Community-Based Cancer Care: A Better All-Around Value

November 29, 2017

By Diana Verrilli    |    November, 2017 

Over the last several years, many promising new cancer therapies have come to the forefront. The pipeline of new cancer drugs has never been richer, and exciting new developments in radiation technologies are providing new innovative treatments that are more precise and effective than ever before.

Unfortunately, these potentially life-saving therapies come with a very high price tag. For instance, Opdivo, a drug that treats certain types of lung cancer after conventional chemotherapy has failed, costs about $150,000 for the initial treatment, and then $14,000 a month for ongoing therapy.1 The yearly outlay for Keytruda, an immune boosting therapy, totals over $152,000.2 New cancer drugs will be even more expensive in the future, as drug costs are projected to grow 7.5 % to 10.5 % annually through 2020.3 The price could easily reach several hundred thousand dollars for a course of treatment for many of the new drugs currently in clinical trials.

Read More

Exciting New Advancements in Personalized Breast Cancer Treatment Are Improving Outcomes and Patients’ Lives

November 3, 2017

By Neelima Denduluri, M.D.    |    October, 2017 

In my career as a medical oncology and breast cancer specialist, I have seen great advancements in the treatment of breast cancer with innovative new drugs and therapy. The outlook for breast cancer patients has never been better, as promising new developments are leading to more effective preventative strategies and late-stage treatments.

Read More

Diagnostic Imaging and Radiation Therapy Play an Important Role in Cancer Care

September 29, 2017

I’ve seen great advancements occur over the last several decades in diagnostic imaging and radiation therapy, and today they are vital components of cancer care. Roughly 60 percent of patients undergo radiation and, as technology advances, there may be even more uses for it in the future.  

How radiation therapy is used

Radiation therapy is the primary treatment modality in many cancers. Head and neck cancers are a good example. Radiation alone without chemotherapy is highly effective in small and medium sized oropharyngeal and laryngeal carcinomas, preserving voice and swallowing function while treating the cancer.
Similarly, prostate cancer can be successfully treated with radiation. Patients with small cancers, as well as those who have locally advanced prostate cancer, have an increased risk of incontinence and impotence after a radical prostatectomy. By combining hormone therapy, external beam radiation, or internal beam radiation (brachytherapy), continence and erectile function can usually be maintained.

Read More

The US Oncology Network Enables World-Class Genetic Services through Its GREAT Program

August 30, 2017

Public awareness of hereditary cancer syndromes has come to the forefront over the last several years, due in part to celebrity disclosures. Community-based oncology practices play an increasingly important role in identifying patients and families who are at hereditary risk for cancer.

Preventing cancer, not just treating it

Genetic testing is an important part of comprehensive cancer care. Testing is an opportunity to provide cancer prevention strategies to patients with a hereditary risk of cancer. A defined genetic risk evaluation program enables practices to do more than just treat the disease. For many people that carry mutations, there are both preventative and patient management consensus guidelines for their care. Likewise, some patients whose testing does not reveal a hereditary mutation may still require a management plan based upon their family history.

Read More

The Oncology Care Model: Where Are We One Year Later?

July 18, 2017

July 1 marks the one year anniversary of the Center for Medicare and Medicaid Innovation (CMMI) Oncology Care Model (OCM), a bold new program focused on providing higher quality, more coordinated cancer care for Medicare beneficiaries with attention on managing costs. The program provides upfront payments to fund practice transformation with the expectation that practices will use these funds to provide enhanced services to patients, submit quality metrics and learn from data sharing.

Read More

The US Oncology Network Demonstrates Leadership in Cancer Research with over 40 Presentations at ASCO

June 19, 2017

Many physicians and clinicians across The US Oncology Network (“The Network”) have just returned from the American Society of Clinical Oncology’s (ASCO) Annual Meeting. As one of the largest cancer meetings in the world, this event brings together more than 35,000 oncology professionals from around the globe. This year’s conference was very energizing, highlighting many promising new therapies and care strategies, while enabling networking opportunities with some of the brightest minds in oncology research and cancer care.

The conference also enables us to meet with our pharma partners. We had several meetings with manufacturers about drugs in their development pipeline, with discussions focusing on how we might accelerate the completion of their trials to speed FDA approval or approval for new indications. Additionally, we identified about 40 new clinical trials we might participate in with our pharma partners in the upcoming year.

Read More

Celebrating Oncology Nursing Month: A Time to Honor Dedicated Professionals Who Touch So Many Lives

May 4, 2017

May is Oncology Nursing Month, a time set aside to honor our special medical professionals who have dedicated their careers to serving cancer patients. There are many different types of oncology nurses throughout The US Oncology Network (“The Network”), including those who work in infusion, radiation, surgery, gynecology, research and management, as well as nurse navigators and patient educators.

Oncology nurses make a difference in patients’ lives every day by being their advocate and educator, guiding them through treatment, celebrating their victories, and providing comfort in times of need―all while ensuring the patient receives the best care possible. The US Oncology Network thanks all of our compassionate, highly-skilled professionals who not only provide exemplary physical care, but also offer psychosocial support to patients and their families throughout the care continuum.

Focus on Nurse Navigation

Read More